Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment
Abstract
None of the registries has provided a risk estimate exceeding that expected in the disorder treated, and no pattern of defects has been observed. Whereas information from the larger registries is reassuring regarding risk, these studies cannot rule out possible small excess risks from use of these d …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
pregnancy
female
Prospective Studies
risk factors
pregnancy complications
abnormalities
pregnancy outcome*
antiviral agents / adverse effects
pregnancy trimester
pmid:10649172
doi:10.1016/s0002-9378(00)70506-0
r reiff-eldridge
c r heffner
e b andrews
drug-induced / epidemiology*
acyclovir / adverse effects
anticonvulsants / adverse effects
drug industry*
epilepsy / drug therapy
lamotrigine
first
registries
sumatriptan / adverse effects
triazines / adverse effects
vasoconstrictor agents / adverse effects
Access
Citation
ID:
115788
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
115788
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
